No Data
On November 20, 2024, The Nasdaq Hearings Panel Granted Exicure Another Extension To Continue Listing, Subject To The Co Evidencing Compliance With All Applicable Criteria For Continued Listing By December 17, 2024
Trending Stocks Today | Forte Biosciences Surges 121.22%
November 20th - US stocks trending in regular trading hours.Gainers: $Forte Biosciences(FBRX.US)$ soars 121.22% to $13.11 with a turnover of $374.5 million. $Quantum-Si(QSI.US)$ surges 118.18% to $1.3
Exicure Signs Equity-Financing Deals With HiTron Systems
Exicure | 10-Q: Q3 2024 Earnings Report
Exicure: HiTron Will Have the Right to Appoint Two Nominees to the Company's Bd of Directors >XCUR
Exicure: To Sell and Issue to HiTron Systems 433,333 Common Shrs, at a Purchase Price of $3 Per Shr >XCUR
No Data
No Data
